158.276 de modificări
Aeglea BioTherapeutics, Inc.: Diferență între versiuni
Aeglea BioTherapeutics, Inc. (modificare)
Versiunea de la data 18 septembrie 2024 15:36
, 18 septembriePagină nouă: Pagina dedicata companiei Aeglea BioTherapeutics, Inc. listata cu simbolul US.AGLE ==Descriere companie== Aeglea BioTherapeutics, Inc. (www.aeglea.com) is a clinical-stage biotechnology company. The Company is focused on developing human enzyme therapeutics to benefit people with rare metabolic diseases. The Company’s product candidates include pegzilarginase and AGLE-177. The Company's lead product candidate, pegzilarginase, is a recombinant human arginase one that enzyma...
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Aeglea BioTherapeutics, Inc. listata cu simbolul US.AGLE ==Descriere companie== Aeglea BioTherapeutics, Inc. (www.aeglea.com) is a clinical-stage biotechnology company. The Company is focused on developing human enzyme therapeutics to benefit people with rare metabolic diseases. The Company’s product candidates include pegzilarginase and AGLE-177. The Company's lead product candidate, pegzilarginase, is a recombinant human arginase one that enzyma...) |
(Nicio diferență)
|